Zivin JA - Search Results

1

Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke.

del Zoppo GJ, Poeck K, Pessin MS, Wolpert SM, Furlan AJ, Ferbert A, Alberts MJ, Zivin JA, Wechsler L, Busse O, et al. del Zoppo GJ, et al. Among authors: zivin ja. Ann Neurol. 1992 Jul;32(1):78-86. doi: 10.1002/ana.410320113. Ann Neurol. 1992. PMID: 1642475 Clinical Trial.

2

Neuroprotective therapies in stroke.

Zivin JA. Zivin JA. Drugs. 1997;54 Suppl 3:83-8; discussion 88-9. doi: 10.2165/00003495-199700543-00012. Drugs. 1997. PMID: 9360855 Review.

3

Thrombolytic therapy in acute ischemic stroke.

Clark WM, Lyden PD, Madden KP, Zivin JA. Clark WM, et al. Among authors: zivin ja. N Engl J Med. 1997 Jan 2;336(1):65-6; author reply 66-7. N Engl J Med. 1997. PMID: 8984333 No abstract available.

4

Diffusion-weighted MRI for diagnosis and treatment of ischemic stroke.

Zivin JA. Zivin JA. Ann Neurol. 1997 May;41(5):567-8. doi: 10.1002/ana.410410503. Ann Neurol. 1997. PMID: 9153516 No abstract available.

5

Thrombolysis with tissue plasminogen activator alters adhesion molecule expression in the ischemic rat brain.

Zhang RL, Zhang ZG, Chopp M, Zivin JA. Zhang RL, et al. Among authors: zivin ja. Stroke. 1999 Mar;30(3):624-9. doi: 10.1161/01.str.30.3.624. Stroke. 1999. PMID: 10066862

6

Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator.

Lapchak PA, Chapman DF, Zivin JA. Lapchak PA, et al. Among authors: zivin ja. Stroke. 2001 Jan;32(1):147-53. doi: 10.1161/01.str.32.1.147. Stroke. 2001. PMID: 11136930

7

Optimized thrombolysis of cerebral clots with tissue-type plasminogen activator in a rabbit model of embolic stroke.

Thomas GR, Thibodeaux H, Bennett WF, Refino CJ, Badillo JM, Errett CJ, Zivin JA. Thomas GR, et al. Among authors: zivin ja. J Pharmacol Exp Ther. 1993 Jan;264(1):67-73. J Pharmacol Exp Ther. 1993. PMID: 8423552

8

Intra-arterial versus intravenous tissue-type plasminogen activator treatment in experimental stroke.

Clark WM, Russell D, Madden KP, Zivin JA. Clark WM, et al. Among authors: zivin ja. Stroke. 1994 Aug;25(8):1699-700. doi: 10.1161/01.str.25.8.1699. Stroke. 1994. PMID: 8093168 No abstract available.

9

A long-half-life and fibrin-specific form of tissue plasminogen activator in rabbit models of embolic stroke and peripheral bleeding.

Thomas GR, Thibodeaux H, Errett CJ, Badillo JM, Keyt BA, Refino CJ, Zivin JA, Bennett WF. Thomas GR, et al. Among authors: zivin ja. Stroke. 1994 Oct;25(10):2072-8; discussion 2078-9. doi: 10.1161/01.str.25.10.2072. Stroke. 1994. PMID: 8091454

10

Tissue plasminogen activator reduces neurological damage after cerebral embolism.

Zivin JA, Fisher M, DeGirolami U, Hemenway CC, Stashak JA. Zivin JA, et al. Science. 1985 Dec 13;230(4731):1289-92. doi: 10.1126/science.3934754. Science. 1985. PMID: 3934754

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results